Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder ... professional of GAD in the past 12 months ...

Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold standard treatment for anxiety disorders in younger ...

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

St. Elizabeth Healthcare Is anxiety a mood disorder or is it a physical reaction to emotional stress? The answer is that it ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

for the treatment of generalized anxiety disorder, in a Phase 2 trial conducted in the United States and United Kingdom, and IHL-675A, an oral fixed dose combination of cannabidiol and ...

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...